Inventor profile of:

Alexander Smith

City:

Apex, North Carolina

Country:

United States

Published Applications:

30

Last publication date:

2026-02-12

Top Assignees for applications by Alexander Smith

The entities that hold a legal rights for patent applications filed by inventor Smith Alexander:

Recent patent applications by Smith Alexander

Alexander Smith from Apex, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-12
US20260041640A1
Human necessities

ADVANTAGEOUS HUMAN DOSAGE REGIMENS FOR ADMINISTRATION OF INX-315

#2 | 2025-11-13
US20250345435A1
Human necessities

ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF

#3 | 2025-10-02
US20250304592A1
Chemistry; metallurgy

MORPHIC FORMS OF G1T38 AND METHODS OF MANUFACTURE THEREOF

#4 | 2025-07-31
US20250243214A1
Chemistry; metallurgy

MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF

#5 | 2025-07-31
US20250243213A1
Chemistry; metallurgy

MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF

#6 | 2025-07-31
US20250243212A1
Chemistry; metallurgy

MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF

#7 | 2025-03-27
US20250101030A1
Chemistry; metallurgy

MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF

#8 | 2024-12-05
US20240398773A1
Human necessities

COMPOSITIONS COMPRISING OTESECONAZOLE

#9 | 2024-10-03
US20240325361A1
Human necessities

Compositions and Methods for Treating Anemia

#10 | 2024-07-04
US20240216511A1
Human necessities

Therapeutic uses for sodium thiosulfate formulations

#11 | 2023-05-25
US20230158145A1
Human necessities

Therapeutic uses for sodium thiosulfate formulations

#12 | 2023-03-30
US20230094886A1
Human necessities

Therapeutic uses for sodium thiosulfate and formulations

#13 | 2023-03-30
US20230094842A1
Human necessities

Therapeutic uses for sodium thiosulfate formulations

#14 | 2023-03-09
US20230071553A1
Human necessities

Compositions and methods for treating anemia

#15 | 2023-02-09
US20230043305A1
Chemistry; metallurgy

Morphic forms of G1T38 and methods of manufacture thereof

#16 | 2022-09-01
US20220274976A1
Chemistry; metallurgy

Compositions, formulations and methods for treating ocular diseases

#17 | 2021-12-16
US20210387993A1
Chemistry; metallurgy

Morphic forms of trilaciclib and methods of manufacture thereof

#18 | 2021-04-29
US20210122755A1
Chemistry; metallurgy

Synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines

#19 | 2020-11-19
US20200361926A1
Chemistry; metallurgy

COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES

#20 | 2020-04-23
US20200123168A1
Chemistry; metallurgy

Morphic forms of G1T38 and methods of manufacture thereof

#21 | 2019-05-09
US20190135820A1
Chemistry; metallurgy

Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines

#22 | 2018-09-06
US20180251457A1
Chemistry; metallurgy

COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES

#23 | 2018-08-23
US20180237431A1
Chemistry; metallurgy

COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES

#24 | 2018-08-23
US20180237430A1
Chemistry; metallurgy

COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES

#25 | 2018-08-23
US20180237429A1
Chemistry; metallurgy

COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES

#26 | 2018-04-05
US20180092892A1
Human necessities

Compositions and methods for treating anemia

#27 | 2018-01-25
US20180022741A1
Chemistry; metallurgy

COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES

#28 | 2016-08-04
US20160220541A1
Human necessities

COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES

#29 | 2016-08-04
US20160220540A1
Human necessities

COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES

#30 | 2014-09-18
US20140275103A1
Chemistry; metallurgy

Compositions, formulations and methods for treating ocular diseases

InventorID:

1608369 ⎘